Ina Schanze

1.3k citations
19 papers · 295 indexed · h-index 11
Topics
Genetics and Neurodevelopmental Disorders (4 papers)Genomic variations and chromosomal abnormalities (3 papers)RNA regulation and disease (2 papers)

In The Last Decade

Ina Schanze

18 papers receiving 291 citations

Peers

Ina Schanze
Comparison fields: 5 of 48
  • Molecular Biology 201
  • Genetics 146
  • Cellular and Molecular Neuroscience 26
  • Immunology 25
  • Surgery 24
Replace Emmanuelle Ranza with:
Emmanuelle Ranza Switzerland
Wendy Alcaraz United States
Dalia Ghoneim United States
Emily Tuttle United States
Keri Ramsey United States
Frédéric Tran Mau‐Them France
Yline Capri France
Stéphanie Valence France
Kirsten Cremer Germany
Linda Manwaring United States
Ina Schanze relative to Emmanuelle Ranza Switzerland Emmanuelle Ranza's profile →
Citations per field
00.5×4.6×
Emmanuelle Ranza · 1×
Citations per year

Countries citing papers authored by Ina Schanze

Since Specialization
Citations

This map shows the geographic impact of Ina Schanze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Schanze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Schanze more than expected).

Fields of papers citing papers by Ina Schanze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Schanze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Schanze. The network helps show where Ina Schanze may publish in the future.

Co-authorship network of co-authors of Ina Schanze

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Schanze. A scholar is included among the top collaborators of Ina Schanze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Schanze. Ina Schanze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 4
2 6
3 1
4 1
5 3
6 32
7 0
8 20
9 15
10 7
11 12
12 31
13 10
14 28
15 24
16 23
17 2
18 31
19 45

About Ina Schanze

Ina Schanze is a scholar working on Genetics, Molecular Biology and Virology, having authored 19 papers that have together received 295 indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (4 papers), Genomic variations and chromosomal abnormalities (3 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Genetics (146 citations), Clinical Biochemistry (21 citations) and Molecular Biology (201 citations). Ina Schanze has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include Martin Zenker, André Reis, Denny Schanze, Christiane Zweier, Sabine Endele, Juliane Hoyer, Anita Rauch, Bronwyn Kerr, Carlos A. Bacino and Silvia Azzarello‐Burri. Their work appears in journals such as Human Molecular Genetics, Human Mutation and Frontiers in Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026